VV
Vaishali Vats
About Vaishali Vats
Data last updated:
Vaishali Vats is an Additional Director at Advench Pharmaceutical Private Limited (since 2025) and Director at Cellcore Biotech Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.8 Lakh; the largest is Advench Pharmaceutical Private Limited at ₹4.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Advench Pharmaceutical Private Limited U47721DL2023PTC412388 | Additional Director | 13 Nov 2025 | 2023 | ₹4.6 Lakh (FY 2025) | Active |
| Cellcore Biotech Private Limited U47721DL2023PTC422844 | Director | 20 Nov 2023 | 2023 | ₹1.2 Lakh (FY 2025) | Active |
Board colleagues of Vaishali Vats
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chander Kant Vats | 10093967 | Advench Pharmaceutical Private Limited , Cellcore Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vaishali Vats
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vaishali Vats
Vaishali Vats currently holds 2 directorships: Advench Pharmaceutical Private Limited (Additional Director, since 13 Nov 2025, revenue ₹4.6 Lakh (FY 2025)); Cellcore Biotech Private Limited (Director, since 20 Nov 2023, revenue ₹1.2 Lakh (FY 2025)).
Vaishali Vats was first appointed on 20 Nov 2023 as Director at Cellcore Biotech Private Limited. The most recent appointment on record is 13 Nov 2025 at Advench Pharmaceutical Private Limited.
The 2 current companies of Vaishali Vats that report revenue have a combined latest revenue of ₹5.8 Lakh: Advench Pharmaceutical Private Limited ₹4.6 Lakh (FY 2025); Cellcore Biotech Private Limited ₹1.2 Lakh (FY 2025).
The current boards of Vaishali Vats's companies include Chander Kant Vats (Advench Pharmaceutical Private Limited).